NN Investment Partners Holdings’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | $3M | Sell |
38,966
-607
| -2% | -$46.8K | 0.02% | 492 |
|
2021
Q4 | $3.5M | Sell |
39,573
-59,220
| -60% | -$5.23M | 0.02% | 472 |
|
2021
Q3 | $7.64M | Buy |
98,793
+62,105
| +169% | +$4.8M | 0.04% | 330 |
|
2021
Q2 | $3.06M | Buy |
36,688
+1,064
| +3% | +$88.8K | 0.02% | 495 |
|
2021
Q1 | $2.69M | Buy |
35,624
+659
| +2% | +$49.7K | 0.02% | 503 |
|
2020
Q4 | $3.07M | Buy |
34,965
+9,203
| +36% | +$807K | 0.02% | 458 |
|
2020
Q3 | $1.96M | Sell |
25,762
-6,274
| -20% | -$477K | 0.01% | 491 |
|
2020
Q2 | $3.95M | Buy |
32,036
+4,189
| +15% | +$517K | 0.03% | 387 |
|
2020
Q1 | $2.35M | Buy |
27,847
+2,720
| +11% | +$230K | 0.02% | 428 |
|
2019
Q4 | $2.13M | Sell |
25,127
-3,326
| -12% | -$281K | 0.01% | 486 |
|
2019
Q3 | $1.92M | Buy |
28,453
+5,416
| +24% | +$365K | 0.02% | 474 |
|
2019
Q2 | $1.97M | Buy |
23,037
+3,001
| +15% | +$257K | 0.02% | 466 |
|
2019
Q1 | $1.78M | Sell |
20,036
-5,135
| -20% | -$456K | 0.01% | 500 |
|
2018
Q4 | $2.14M | Sell |
25,171
-156
| -0.6% | -$13.3K | 0.02% | 421 |
|
2018
Q3 | $2.46M | Buy |
25,327
+8,352
| +49% | +$810K | 0.02% | 417 |
|
2018
Q2 | $1.6M | Hold |
16,975
| – | – | 0.01% | 468 |
|
2018
Q1 | $1.38M | Hold |
16,975
| – | – | 0.01% | 500 |
|
2017
Q4 | $1.51M | Sell |
16,975
-8,893
| -34% | -$793K | 0.01% | 484 |
|
2017
Q3 | $2.41M | Buy |
25,868
+4,491
| +21% | +$418K | 0.02% | 452 |
|
2017
Q2 | $1.94M | Hold |
21,377
| – | – | 0.02% | 370 |
|
2017
Q1 | $1.88M | Buy |
21,377
+8,039
| +60% | +$706K | 0.02% | 355 |
|
2016
Q4 | $1.11M | Buy |
13,338
+5,009
| +60% | +$415K | 0.01% | 451 |
|
2016
Q3 | $771K | Sell |
8,329
-4,756
| -36% | -$440K | 0.01% | 533 |
|
2016
Q2 | $1.02M | Sell |
13,085
-3,000
| -19% | -$233K | 0.01% | 458 |
|
2016
Q1 | $1.33M | Buy |
+16,085
| New | +$1.33M | 0.01% | 413 |
|